Simple and sensitive determination of 5-fluorouracil in plasma by high-performance liquid chromatography. Application to clinical pharmacokinetic studies.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Chromatography B: Biomedical Sciences and Applications

• Publication date

  1999-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0378-4347(99)00446-6PMID 10676988
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonlinear pharmacokinetic characteristics of 5-fluorouracil (5-FU) in colorectal cancer patients

  2004cited by this paper
• Nonlinear pharmacokinetics for the elimination of 5-fluorouracil after intravenous administration in cancer patients

  2004cited by this paper
• Phase I and pharmacokinetic evaluation of floxuridine/leucovorin given on the Roswell Park weekly regimen

  2004cited by this paper
• Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients.

  1998cited by this paper
• Rapid and sensitive high-performance liquid chromatographic analysis of halogenopyrimidines in plasma.

  1997cited by this paper
• Bimonthly high dose leucovorin and 5‐fluorouracil 48‐hour continuous infusion in patients with advanced colorectal carcinoma

  1997cited by this paper
• Simultaneous determination of dihydrofluorouracil and 5-fluorouracil in plasma by high-performance liquid chromatography.

  1997cited by this paper
• High-performance liquid chromatographic assay of 5-fluorouracil in human erythrocytes, plasma and whole blood.

  1997cited by this paper
• Simple high-performance liquid chromatographic method for the quantitation of 5-fluorouracil in human plasma.

  1996cited by this paper
• Relationship between 5‐fluorouracil (5‐FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5‐FU

  1996cited by this paper
• Determination of the concentrations of 5-fluorouracil and its metabolites in rabbit plasma and tissues by high-performance liquid chromatography.

  1994cited by this paper
• Relationship between fluorouracil systemic exposure and tumor response and patient survival.

  1994cited by this paper
• Development and Validation of a Limited Sampling Strategy for 5‐Fluorouracil Given by Bolus Intravenous Administration

  1993cited by this paper
• Pharmacokinetic and pharmacodynamic analysis of fluorouracil during 72-hour continuous infusion with and without dipyridamole.

  1991cited by this paper
• 5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer.

  1989cited by this paper
• Overview of clinical trials using 5‐fluorouracil and leucovorin for the treatment of colorectal cancer

  1989cited by this paper
• Dose Versus pharmacokinetics for predicting tolerance to 5‐day continuous infusion of 5‐FU

  1988cited by this paper
• High-performance liquid chromatographic analysis of fluoropyrimidine nucleosides and fluorouracil in plasma.

  1987cited by this paper
• Analysis of 5'-deoxy-5-fluorouridine and 5-fluorouracil in human plasma and urine by high-performance liquid chromatography.

  1985cited by this paper
• Sensitive high-performance liquid chromatographic method for the determination of 5-fluorouracil in plasma.

  1985cited by this paper
• Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion.

  1980cited by this paper
• A sensitive method for determination of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in human plasma by high-pressure liquid chromatography.

  1980cited by this paper
• Simultaneous liquid chromatography of 5-fluorouracil, uridine, hypoxanthine, xanthine, uric acid, allopurinol, and oxipurinol in plasma.

  1980cited by this paper
• Comparison of liquid- and gas-liquid chromatographic assays of 5-fluorouracil in plasma.

  1979cited by this paper

• Safeguarding Patients, Relatives, and Nurses: A Screening Approach for Detecting 5-FU Residues on Elastomeric Infusion Pumps Using HPLC-DAD

  2025cites this paper
• Covalent Organic Framework (C6N6) as a Drug Delivery Platform for Fluorouracil to Treat Cancerous Cells: A DFT Study

  2022cites this paper
• GC Determination of Fluorouracil in Serum by Using Hexafluroroacetylacetone as Derivatizing Reagent.

  2022cites this paper
• Development of an HPLC-DAD Method for the Extraction and Quantification of 5-Fluorouracil, Uracil, and 5-Fluorodeoxyuridin Monophosphate in Cells and Culture Media of Lactococcus lactis

  2022cites this paper
• A review of the bioanalytical methods for the quantitative determination of capecitabine and its metabolites in biological matrices.

  2020cites this paper
• Analytical method development and validation of anticancer agent, 5-fluorouracil, and its metabolites in biological matrices: An updated review

  2020cites this paper
• Comparative effects of surfactants on the behavior of an anticancer drug potentiometric sensor

  2020cites this paper
• Extraordinary enhancement of a 5-fluorouracil electrode by praepagen HY micellar solutions

  2020cites this paper
• Development and Validation of a New Stability Indicating Reversed-phase High‑Performance Liquid Chromatography Method for the Simultaneous Estimation of Tegafur and Uracil in Capsule Dosage Form

  2018cites this paper
• RP-HPLC estimation of Capecitabine in pure and pharmaceutical dosage form

  2016cites this paper
• Electrochemical Sensor for the Determination of Anticancer Drug 5‐ Fluorouracil at Glucose Modified Electrode

  2016cites this paper
• Development and optimization of fast and new reversed-phase HPLC method for analysis of 5-fluorouracil in human and rabbit plasma.

  2015influential citation
• A sensitive electrochemical DNA biosensor for antineoplastic drug 5-fluorouracil based on glassy carbon electrode modified with poly(bromocresol purple).

  2015cites this paper
• Integrated Master in Bioengineering Degradation of 5-Fluorouracil in waters

  2015cites this paper
• Development and validation of an HPLC method for the determination of fluorouracil in polymeric nanoparticles

  2013cites this paper
• Phase I, pharmacokinetic, and bone marrow drug-level studies of trimonthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers

  2011cites this paper
• Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency

  2011cites this paper
• A review of analytical methods for the determination of 5-fluorouracil in biological matrices

  2010cites this paper
• Quantitation of 5-fluorouracil (5-FU) in human plasma by liquid chromatography/electrospray ionization tandem mass spectrometry.

  2008cites this paper
• Highlights from: 5-Fluorouracil Drug Management Pharmacokinetics and Pharmacogenomics Workshop

  2007cites this paper
• Highlights from: 5-Fluorouracil Drug Management Pharmacokinetics and Pharmacogenomics Workshop; Orlando, Florida; January 2007.

  2007cites this paper
• Improved determination of 5-fluorouracil and its prodrug tegafur in pharmaceuticals by large-volume sample stacking in CE.

  2007cites this paper
• Extraction sur phase solide et analyses par HPLC du 5-fluoro-uracile plasmatique

  2005cites this paper
• A simple and rapid high‐performance liquid chromatographic (HPLC) method for 5‐fluorouracil (5‐FU) assay in plasma and possible detection of patients with impaired dihydropyrimidine dehydrogenase (DPD) activity

  2004cites this paper
• Simple determination of capecitabine and its metabolites by liquid chromatography with ultraviolet detection in a single injection.

  2004cites this paper
• High performance liquid chromatographic determination of some co-administered anticancer drugs in pharmaceutical preparations and in spiked human plasma.

  2004cites this paper
• Determination of 5-Fluorouracil and Its Prodrug Tegafur in Plasma and Tissue by High-Performance Liquid Chromatography in a Single Injection: Validation for Application in Clinical Pharmacokinetic Studies

  2003cites this paper
• Rapid determination of 5-fluorouracil in plasma using capillary electrophoresis.

  2003cites this paper
• Simultaneous HPLC determination of 5-fluorouracil and its metabolites in plasma of cancer patients.

  2002cites this paper